The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 533 KB) and Technical Notes (PDF, 752 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Figure 19.6

CSR Figure 19.6: SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas, Females


Figure 19.6

Rates per 100,000 for Non-Hodgkin Lymphoma, All Races, Female, All Ages
Year Delay-Adjusted SEER 9 Incidence
1975-2010
Delay-Adjusted SEER 9 Incidence
1975-2010
Modeled (from Joinpoint)
Observed SEER 9 Incidence
1975-2010
Observed SEER 9 Incidence
1975-2010
Modeled (from Joinpoint)
Delay-Adjusted SEER 13 Incidence
1992-2010
Delay-Adjusted SEER 13 Incidence
1992-2010
Modeled (from Joinpoint)
Observed SEER 13 Incidence
1992-2010
Observed SEER 13 Incidence
1992-2010
Modeled (from Joinpoint)
1975 9.6 9.6 9.6 9.6    
1976 10.0 9.8 10.0 9.8    
1977 9.8 10.1 9.8 10.1    
1978 10.1 10.5 10.1 10.4    
1979 11.2 10.8 11.2 10.8    
1980 10.8 11.1 10.8 11.1    
1981 11.8 11.4 11.8 11.4    
1982 11.6 11.8 11.6 11.8    
1983 11.9 12.1 11.9 12.1    
1984 12.8 12.5 12.8 12.5    
1985 13.2 12.9 13.2 12.9    
1986 13.0 13.3 13.0 13.3    
1987 13.4 13.7 13.4 13.7    
1988 14.1 14.1 14.1 14.1    
1989 13.8 14.3 13.8 14.3    
1990 14.8 14.5 14.8 14.5    
1991 14.6 14.7 14.6 14.7    
1992 15.0 14.9 14.9 14.9 14.6 14.7 14.6 14.7
1993 15.0 15.1 15.0 15.1 14.5 14.9 14.5 14.8
1994 15.8 15.3 15.8 15.3 15.3 15.1 15.3 15.0
1995 15.4 15.5 15.4 15.5 15.2 15.3 15.2 15.2
1996 15.5 15.8 15.5 15.7 15.2 15.5 15.2 15.4
1997 16.5 16.0 16.4 16.0 16.0 15.7 16.0 15.6
1998 16.9 16.2 16.8 16.2 16.4 15.9 16.4 15.8
1999 16.3 16.4 16.3 16.4 16.2 16.1 16.2 16.1
2000 16.1 16.7 16.1 16.6 16.0 16.3 16.0 16.3
2001 16.5 16.9 16.5 16.9 16.2 16.5 16.2 16.5
2002 17.1 17.2 17.0 17.1 16.5 16.7 16.5 16.7
2003 17.6 17.4 17.5 17.3 17.2 17.0 17.2 16.9
2004 18.0 17.6 17.9 17.6 17.5 17.2 17.4 17.1
2005 17.1 17.5 17.0 17.4 16.6 17.1 16.5 17.0
2006 17.3 17.4 17.2 17.3 17.0 17.0 16.9 16.9
2007 17.5 17.3 17.3 17.1 16.8 16.9 16.7 16.8
2008 17.1 17.2 16.9 17.0 16.7 16.9 16.5 16.6
2009 17.4 17.1 17.2 16.8 17.2 16.8 16.9 16.5
2010 17.3 17.0 17.0 16.7 17.2 16.7 16.9 16.4
2011 16.6 16.9 16.1 16.5 16.1 16.6 15.7 16.3
Rates per 100,000 for Non-Hodgkin Lymphoma, White, Female, All Ages
Year Delay-Adjusted SEER 9 Incidence
1975-2010
Delay-Adjusted SEER 9 Incidence
1975-2010
Modeled (from Joinpoint)
Observed SEER 9 Incidence
1975-2010
Observed SEER 9 Incidence
1975-2010
Modeled (from Joinpoint)
Delay-Adjusted SEER 13 Incidence
1992-2010
Delay-Adjusted SEER 13 Incidence
1992-2010
Modeled (from Joinpoint)
Observed SEER 13 Incidence
1992-2010
Observed SEER 13 Incidence
1992-2010
Modeled (from Joinpoint)
1975 10.1 10.0 10.1 10.0    
1976 10.5 10.3 10.5 10.3    
1977 10.2 10.6 10.2 10.6    
1978 10.7 10.9 10.7 10.9    
1979 11.8 11.3 11.8 11.3    
1980 11.2 11.6 11.2 11.6    
1981 12.4 12.0 12.4 12.0    
1982 12.1 12.3 12.1 12.3    
1983 12.4 12.7 12.4 12.7    
1984 13.5 13.1 13.5 13.1    
1985 13.9 13.5 13.9 13.5    
1986 13.8 13.9 13.8 13.9    
1987 14.0 14.3 14.0 14.3    
1988 14.9 14.8 14.9 14.8    
1989 14.5 15.0 14.5 15.0    
1990 15.5 15.2 15.5 15.2    
1991 15.3 15.4 15.3 15.4    
1992 15.8 15.7 15.8 15.7 15.6 15.5 15.6 15.5
1993 15.7 15.9 15.7 15.9 15.3 15.7 15.3 15.7
1994 16.6 16.1 16.6 16.1 16.2 15.9 16.2 15.9
1995 16.1 16.4 16.0 16.3 16.0 16.1 16.0 16.1
1996 16.2 16.6 16.2 16.6 16.1 16.4 16.0 16.3
1997 17.5 16.9 17.5 16.8 16.8 16.6 16.8 16.5
1998 17.8 17.1 17.7 17.0 17.2 16.8 17.2 16.8
1999 17.3 17.4 17.3 17.3 17.4 17.1 17.3 17.0
2000 17.1 17.6 17.0 17.5 17.0 17.3 16.9 17.2
2001 17.1 17.9 17.1 17.8 17.1 17.5 17.0 17.5
2002 18.0 18.1 17.9 18.1 17.6 17.8 17.5 17.7
2003 18.6 18.4 18.5 18.3 18.1 18.0 18.0 17.9
2004 19.0 18.7 18.8 18.6 18.6 18.3 18.4 18.2
2005 18.3 18.6 18.1 18.4 17.9 18.2 17.7 18.0
2006 18.6 18.5 18.3 18.2 18.4 18.2 18.1 17.9
2007 18.6 18.4 18.3 18.0 18.1 18.1 17.8 17.8
2008 17.9 18.3 17.5 17.8 17.7 18.0 17.3 17.6
2009 18.3 18.2 17.8 17.6 18.4 18.0 18.0 17.5
2010 18.5 18.1 17.9 17.4 18.5 17.9 18.0 17.3
2011 17.6 18.0 16.7 17.3 17.1 17.8 16.3 17.2
Rates per 100,000 for Non-Hodgkin Lymphoma, Black, Female, All Ages
Year Delay-Adjusted SEER 9 Incidence
1975-2010
Delay-Adjusted SEER 9 Incidence
1975-2010
Modeled (from Joinpoint)
Observed SEER 9 Incidence
1975-2010
Observed SEER 9 Incidence
1975-2010
Modeled (from Joinpoint)
Delay-Adjusted SEER 13 Incidence
1992-2010
Delay-Adjusted SEER 13 Incidence
1992-2010
Modeled (from Joinpoint)
Observed SEER 13 Incidence
1992-2010
Observed SEER 13 Incidence
1992-2010
Modeled (from Joinpoint)
1975 5.3 6.1 5.3 6.1    
1976 4.9 6.2 4.9 6.3    
1977 6.1 6.4 6.1 6.5    
1978 5.2 6.6 5.2 6.6    
1979 5.9 6.8 5.9 6.8    
1980 7.2 7.0 7.2 7.0    
1981 5.0 7.2 5.0 7.2    
1982 10.0 7.4 10.0 7.4    
1983 9.6 7.7 9.6 7.7    
1984 6.9 7.9 6.9 7.9    
1985 8.3 8.1 8.3 8.1    
1986 8.5 8.4 8.5 8.4    
1987 10.1 8.6 10.1 8.6    
1988 8.5 8.9 8.5 8.8    
1989 9.7 9.1 9.7 9.1    
1990 10.9 9.4 10.9 9.4    
1991 10.4 9.7 10.4 9.6    
1992 9.7 10.0 9.6 9.9 9.2 9.0 9.2 8.9
1993 9.7 10.3 9.7 10.2 10.0 9.4 10.0 9.4
1994 8.8 10.6 8.7 10.5 8.6 10.0 8.6 9.9
1995 11.4 10.9 11.3 10.8 10.2 10.5 10.2 10.5
1996 12.3 11.2 12.3 11.1 11.8 11.1 11.7 11.1
1997 10.8 11.5 10.8 11.5 11.8 11.7 11.8 11.7
1998 12.5 11.9 12.4 11.8 13.1 12.3 13.1 12.4
1999 11.2 12.2 11.1 12.1 11.3 12.4 11.2 12.4
2000 10.7 12.6 10.6 12.5 11.9 12.5 11.8 12.4
2001 14.1 12.9 14.0 12.9 12.7 12.6 12.6 12.5
2002 12.5 13.3 12.4 13.2 11.9 12.7 11.8 12.5
2003 13.7 13.7 13.5 13.6 13.4 12.8 13.3 12.6
2004 14.6 14.1 14.4 14.0 13.7 12.9 13.5 12.6
2005 14.3 14.0 14.0 13.8 13.5 12.9 13.2 12.7
2006 13.2 13.9 12.9 13.6 12.7 13.0 12.4 12.7
2007 13.3 13.8 13.0 13.4 13.4 13.1 13.1 12.8
2008 15.2 13.7 14.8 13.2 13.6 13.2 13.2 12.8
2009 13.1 13.6 12.6 13.1 12.6 13.3 12.2 12.8
2010 13.8 13.5 13.2 12.9 13.1 13.4 12.6 12.9
2011 13.0 13.4 12.2 12.7 13.6 13.5 12.8 12.9
Annual Percent Changes for the most recent trend in the data series as calculated by Joinpoint
Non-Hodgkin Lymphoma, Female, All Ages
Data Series Year Range for APC APC
Delay-Adjusted SEER 9 Incidence, All Races, 1975-20102004-11-0.6
Observed SEER 9 Incidence, All Races, 1975-20102004-11-0.9*
Delay-Adjusted SEER 13 Incidence, All Races, 1992-20102004-11-0.5
Observed SEER 13 Incidence, All Races, 1992-20102004-11-0.7
Delay-Adjusted SEER 9 Incidence, White, 1975-20102004-11-0.5
Observed SEER 9 Incidence, White, 1975-20102004-11-1.0*
Delay-Adjusted SEER 13 Incidence, White, 1992-20102004-11-0.4
Observed SEER 13 Incidence, White, 1992-20102004-11-0.8
Delay-Adjusted SEER 9 Incidence, Black, 1975-20102004-11-0.7
Observed SEER 9 Incidence, Black, 1975-20102004-11-1.4
Delay-Adjusted SEER 13 Incidence, Black, 1992-20101998-110.7
Observed SEER 13 Incidence, Black, 1992-20101998-110.3

Footnotes:

a Source: SEER 9 areas and SEER 13 areas. Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103).

Regression lines and APCs are calculated using the Joinpoint Regression Program Version 4.1.0, April 2014, National Cancer Institute.

The APC is the Annual Percent Change for the regression line segments.

* The APC is significantly different from zero (p < 0.05).

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.